Castlight Health, inc. (NYSE:CSLT) has been given a consensus rating of “Hold” by the ten brokerages that are currently covering the company, MarketBeat.com reports. Three equities research analysts have rated the stock with a sell rating, five have assigned a hold rating and two have given a buy rating to the company. The average 12-month price target among analysts that have updated their coverage on the stock in the last year is $4.45.

Several equities analysts recently issued reports on CSLT shares. ValuEngine cut Castlight Health, inc. from a “hold” rating to a “sell” rating in a report on Thursday, August 10th. BidaskClub cut Castlight Health, inc. from a “sell” rating to a “strong sell” rating in a report on Thursday, August 24th. Cowen and Company reiterated a “market perform” rating and issued a $4.50 price target (up previously from $4.00) on shares of Castlight Health, inc. in a report on Thursday, August 3rd. Dougherty & Co started coverage on Castlight Health, inc. in a report on Wednesday, May 10th. They issued a “buy” rating and a $5.50 price target on the stock. Finally, Zacks Investment Research upgraded Castlight Health, inc. from a “sell” rating to a “hold” rating in a report on Tuesday, June 27th.

In other Castlight Health, inc. news, CEO John C. Doyle sold 35,184 shares of the firm’s stock in a transaction dated Thursday, August 17th. The stock was sold at an average price of $3.65, for a total transaction of $128,421.60. Following the transaction, the chief executive officer now owns 75,639 shares in the company, valued at $276,082.35. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, CFO Mangini Siobhan Nolan sold 28,639 shares of the firm’s stock in a transaction dated Friday, August 18th. The stock was sold at an average price of $3.66, for a total value of $104,818.74. Following the transaction, the chief financial officer now owns 41,622 shares in the company, valued at approximately $152,336.52. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 208,287 shares of company stock worth $795,240. Company insiders own 24.38% of the company’s stock.

Institutional investors have recently modified their holdings of the company. FMR LLC boosted its position in shares of Castlight Health, inc. by 49.2% in the second quarter. FMR LLC now owns 11,433,928 shares of the software maker’s stock worth $47,451,000 after buying an additional 3,768,009 shares during the period. Vanguard Group Inc. boosted its position in shares of Castlight Health, inc. by 36.0% in the second quarter. Vanguard Group Inc. now owns 3,636,948 shares of the software maker’s stock worth $15,094,000 after buying an additional 963,188 shares during the period. Prudential PLC boosted its position in shares of Castlight Health, inc. by 23.5% in the second quarter. Prudential PLC now owns 2,002,706 shares of the software maker’s stock worth $8,311,000 after buying an additional 380,920 shares during the period. Gagnon Securities LLC boosted its position in shares of Castlight Health, inc. by 2.5% in the first quarter. Gagnon Securities LLC now owns 1,446,792 shares of the software maker’s stock worth $5,281,000 after buying an additional 35,374 shares during the period. Finally, Maverick Capital Ltd. boosted its position in shares of Castlight Health, inc. by 2.8% in the second quarter. Maverick Capital Ltd. now owns 1,221,809 shares of the software maker’s stock worth $5,071,000 after buying an additional 33,735 shares during the period. Hedge funds and other institutional investors own 41.30% of the company’s stock.

Castlight Health, inc. (NYSE:CSLT) opened at 3.65 on Tuesday. Castlight Health, inc. has a 12 month low of $3.05 and a 12 month high of $5.50. The firm’s 50-day moving average is $4.17 and its 200-day moving average is $3.83. The stock’s market cap is $480.66 million.

Castlight Health, inc. (NYSE:CSLT) last posted its quarterly earnings results on Wednesday, August 2nd. The software maker reported ($0.07) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.09) by $0.02. The business had revenue of $32.10 million for the quarter, compared to analysts’ expectations of $31.14 million. Castlight Health, inc. had a negative return on equity of 36.30% and a negative net margin of 42.54%. The firm’s quarterly revenue was up 36.0% compared to the same quarter last year. During the same quarter last year, the business earned ($0.11) earnings per share. On average, equities analysts forecast that Castlight Health, inc. will post ($0.25) earnings per share for the current fiscal year.

TRADEMARK VIOLATION NOTICE: This news story was published by American Banking News and is the property of of American Banking News. If you are reading this news story on another domain, it was copied illegally and republished in violation of US & international copyright and trademark legislation. The legal version of this news story can be accessed at https://www.americanbankingnews.com/2017/08/29/castlight-health-inc-cslt-given-average-recommendation-of-hold-by-brokerages.html.

About Castlight Health, inc.

Castlight Health, Inc offers a health benefits platform that engages employees to make healthcare decisions, and enables employers to communicate and measure their benefit programs. The Company operates through cloud-based products segment. Its technology offering aggregates data and applies analytics to make healthcare data transparent.

Analyst Recommendations for Castlight Health, inc. (NYSE:CSLT)

Receive News & Ratings for Castlight Health inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Castlight Health inc. and related companies with MarketBeat.com's FREE daily email newsletter.